Table 2.
SCAP biological relevance in terms of differentiation and/or paracrine potential with references included.
SCAP differentiation potential | In vivo/in vitro | Cell secretome/ implanted cells | Factors involved | Ref | |
---|---|---|---|---|---|
Osteogenic/ odontogenic | Both | Implanted cells | DSPP BSP ALP BGLAP BMP RUNX2 |
Bakopoulou et al., 2013 | |
Adipogenic | In vitro | Implanted cells | LPL PPAR gamma2 |
Ding et al., 2010; Bakopoulou et al., 2013 | |
Chondrogenic | In vitro | Implanted cells | Proteo-glycans | Cao et al., 2013 | |
Neurogenic | Both | Cell secretome GDNF NT3 CNP Survivin NSE VEGFA BFGF |
BDNF NGF GDNF GAD NeuN Nestin GFAP NCAM Neuro-filament |
Sonoyama et al., 2006; Bakopoulou et al., 2013, 2015; de Almeida et al., 2014; Yuan et al., 2014; Germain et al., 2015 | |
Angiogenic | Both | Cell secretome bFGF PDGF VEGF angiopoietin-1 MMPs Endostatin IGFBP-3 ephrinB2 HIF-1 |
+ uPA, EDN2 DPPIV ANG |
– PAI-1 THBS1 TIMP1/4 PTX3 PGGF PAO-1 |
Hilkens et al., 2017 Yuan et al., 2014 |